New Clot-Sucking device could limit heart attack damage
NCT ID NCT06887413
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests whether using a special catheter to remove blood clots during emergency heart attack treatment can reduce heart muscle damage. About 140 patients having a major heart attack will be randomly assigned to get either standard care or standard care plus clot removal. The main goal is to see if the clot removal group has less scarring and better heart function on MRI scans a few days later.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Thrombus aspiration with Indigo Aspiration System (CAT RX catheter)
- What this could lead to
- If successful, this could lead to a standard procedure to reduce heart muscle damage after a major heart attack, potentially improving long-term heart function.
- What could go wrong
- This is a relatively small, early-stage trial (140 patients) testing a device procedure. Previous studies on thrombus aspiration have shown mixed results, so it may not prove beneficial. Risks include procedural complications like vessel damage or stroke.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTERIOR MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IRCCS Ospedale San Raffaele
RECRUITINGMilan, Milani, 20132, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.